1 Department of Pediatric and Adolescent Oncology and INSERM U1015, Gustave Roussy Cancer Campus, Universiteé Paris-Saclay, Villejuif 94805, France. Electronic address: [email protected].
2 Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Hospital Ninño Jesués, Madrid, Spain; Princess Maéxima Center for Pediatric Oncology, Utrecht, Netherlands.
3 Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
4 Paediatric and Adolescent Oncology Drug Development Unit and Division of Clinical Studies, Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, UK.
5 Department of Pediatric Oncology, Timone Hospital, AP-HM, Marseille, France; Reverse Molecular Pharmacology in Pediatric Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, CNRS, INSERM, Marseille, France; Metronomics Global Health Initiative, Marseille, France.